首頁 > 市場調查報告書 > 醫療設備

藥物遞輸設備拋棄式

市場調查報告書

商品編碼

1863891

預填充式注射器市場：按材料、藥物類型、設計、產品類型、性別、製造方法、最終用戶和地區分類

Prefilled Syringes Market, By Material, By Drug Type, By Design, By Product Type, By Usability, By Manufacturing Method, By End User, By Geography

出版日期: 2025年10月04日 | 出版商:

Coherent Market Insights | 英文 401 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2025 年，預填充式注射器市場價值將達到 71.8 億美元，預計到 2032 年將達到 105.1 億美元，2025 年至 2032 年的複合年成長率為 5.6%。

報告範圍		報告詳情
基準年：	2024	2025年市場規模：	71.8億美元
性能數據：	2020年至2024年	預測期：	2025年至2032年
預測期（2025-2032年）複合年成長率：	5.60%	2032年價值預測	105.1億美元

預填充式注射器是預先裝有待注射藥物的一次性注射器。它們是單劑量注射器，針頭由製造商預先安裝。由於這些注射器已預先填充藥物，護士和患者無需準備藥物並將其吸入針頭；正確的劑量已在注射器內，可實現快速注射。此外，預填充式注射器因其高精度而使用起來更安全。一些預填充式注射器藥筒設計用於自吸式注射器，透過穿透皮膚輸送藥物，無需按壓活塞。這確保了藥物的順暢輸送，並確保注射達到適當的深度。

市場動態

慢性病發病率的不斷上升預計將推動預填充式注射器作為治療選擇的需求，從而在預測期內促進市場成長。例如，根據美國疾病管制與預防中心 (CDC) 於 2022 年 7 月更新的慢性病數據，美國約有 60% 的成年人患有某種慢性病，超過 40% 的成年人患有兩種或兩種以上的慢性病。癌症是全球影響人數最多的慢性病。例如，根據 GLOBOCAN 2020 報告，2020 年全球癌症病例總數約為 19,292,789 例。預計到2040年，這一數字將增加至28,887,940例。多種癌症正在使用新型藥物和生物製藥進行治療，預計將增加2025年至2032年預測期內對預填充式注射器的需求。因此，全球癌症病例的增加預計將在預測期內推動預填充式注射器市場的成長。

隨著市場參與企業不斷拓展產品系列，監管機構核准的藥品數量持續增加，預計將推動市場在預測期內成長。例如，2022年12月，跨國製藥公司Alembic Pharmaceuticals Limited宣布，其美國劑量預核准式注射器裝的氟維司群注射預填充式注射器（250毫克/5毫升，50毫克/毫升）的簡略新藥申請（ANDA）已獲得食品藥物管理局（FDA）的最終批准。氟維司群注射液是一種雌激素受體拮抗劑，用於治療乳癌。

本次調查的主要特點

本報告對全球預填充式注射器市場進行了詳細分析，以 2024 年為基準年，對 2025 年至 2032 年的預測期內市場規模和復合年成長率 (%) 進行了預測。
該報告重點介紹了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
該報告還提供了有關市場促進因素、限制因素、機會、新產品發布或核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
本報告根據以下參數對全球預填充式注射器市場的主要參與者進行了分析：公司概況、產品系列、主要亮點、財務表現和策略。
本報告的研究結果將使負責人和企業經營團隊能夠就即將推出的產品、類型升級、市場擴張和行銷策略做出明智的決策。
本報告的目標受眾是全球預填充式注射器市場的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過各種用於分析全球預填充式注射器市場的策略矩陣輕鬆做出決策。

Gerresheimer AG
Becton, Dickinson and Company
West Pharmaceutical Services, Inc.
Terumo Corporation
Nipro Europe Group Companies
B.Braun SE
GSK plc.
Pfizer Inc.
Bayer AG
Polymedicure
Amsino International, Inc.
Leeford Healthcare Limited
Torrent Pharmaceuticals Ltd.
Regeneron Pharmaceuticals Inc.
Ypsomed AG
SOL-Millennium
Stevanato Group SpA

第13章各節

調查方法
關於出版商

簡介目錄

Product Code: CMI162

Prefilled Syringes Market is estimated to be valued at USD 7.18 Bn in 2025 and is expected to reach USD 10.51 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5.6% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 7.18 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	5.60%	2032 Value Projection:	USD 10.51 Bn

Pre-filled syringes are single-use syringes that are pre-loaded with the medication that will be injected. It is a single dose of medicine with a needle attached by the manufacturer. As these syringes are prefilled, nurses or patients do not need to prepare the medication and pull it into the needle; instead, the appropriate dosage is already present in the barrel and is ready for speedy injection. Moreover, prefilled syringes are safer to use since they are highly accurate. Some cartridges of prefilled syringes are made to fit into self-aspirating syringes, which penetrate the skin and provide drugs without the need to press a plunger. This guarantees that doses are supplied smoothly and that injections reach the proper depth.

Market Dynamics

Increasing incidence of chronic diseases which leads to driving the demand of prefilled syringes as its treatment is expected to fuel the market growth over the forecast period. For instance, according to the Centers for Disease Control and Prevention data on chronic diseases updated in July 2022, around six in ten adults in the U.S. were affected by a type of chronic disease, and over four in ten adults were affected by two or more chronic diseases. Cancer is the most common chronic disease affecting people worldwide. For instance, according to the GLOBOCAN 2020 report, the total number of people in the world affected by cancer in 2020 accounted for around 19,292,789 cases. The number is estimated to rise to 28,887,940 cases by 2040. Several types of cancer are treated with the help of novel drugs and biologics, which is expected to increase the demand for prefilled syringes over forecast period 2025-2032. Thus, the rising cancer cases across the world is expected to boost the growth of the prefilled syringes market over the forecast period.

The increasing approvals from various regulatory agencies by market players to expand product portfolio is expected to drive the market growth over the forecast period. For instance, in December 2022, Alembic Pharmaceuticals Limited, a multinational pharmaceutical company, announced that it had received final approval from the U.S. Food & Drug Administration for its Abbreviated New Drug Application (ANDA), Fulvestrant Injection, 250 mg/5 mL (50 mg/mL) per Single-Dose Prefilled Syringe. Fulvestrant Injection is an estrogen receptor antagonist indicated for the treatment of breast cancer.

Key features of the study

This report provides in-depth analysis of the global prefilled syringes market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global prefilled syringes market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Gerresheimer AG, Becton Dickinson and Company, West Pharmaceutical Services, Inc., Terumo Corporation, Nipro Europe Group Companies, B. Braun SE, Sanofi, GSK plc., Pfizer Inc., Bayer AG, Polymedicure, Amsino International, Inc., Leeford Healthcare Limited, Torrent Pharmaceuticals Ltd., Regeneron Pharmaceuticals Inc., Ypsomed AG, SOL-Millennium, and Stevanato Group S.p.A.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global prefilled syringes market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global prefilled syringes market

Market Segmentation

Global Prefilled Syringes Market, By Material
- Glass
- Plastic/Polymer
Global Prefilled Syringes Market, By Drug Type
- Biologics
- Monoclonal Antibodies
- Blood Products
- Others (Erythropoietin, Therapeutic proteins, among others)
- Vaccines
- Conjugated Vaccines
- Live Attenuated Vaccines
- Recombinant Vaccines
- Others (Virus-like particles (VLPs), Viral vector vaccines)
- Insulin
- Anticoagulants
- Flush Saline Syringes
- Others
Global Prefilled Syringes Market, By Design
- Single-chamber
- Dual-chamber
- Multi-chambered
Global Prefilled Syringes Market, By Product Type
- Staked in-needle pre-filled syringes
- Needle-free pre-filled syringes
Global Prefilled Syringes Market, By Usability
- Disposable
- Reusable
Global Prefilled Syringes Market, By Manufacturing Method
- Captive
- Merchant
Global Prefilled Syringes Market, By End User
- Hospital
- Clinics
- Ambulatory Surgical Centers
- Others
Global Prefilled Syringes Market, By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
Company Profiles
- Gerresheimer AG
- Becton, Dickinson and Company
- West Pharmaceutical Services, Inc.
- Terumo Corporation
- Nipro Europe Group Companies
- B. Braun SE
- Sanofi
- GSK plc.
- Pfizer Inc.
- Bayer AG
- Polymedicure
- Amsino International, Inc.
- Leeford Healthcare Limited
- Torrent Pharmaceuticals Ltd.
- Regeneron Pharmaceuticals Inc.
- Ypsomed AG
- SOL-Millennium
- Stevanato Group S.p.A.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Material
- Market Snapshot, By Drug Type
- Market Snapshot, By Design
- Market Snapshot, By Product Type
- Market Snapshot, By Usability
- Market Snapshot, By Manufacturing Method
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Attractiveness Analysis
- Market Opportunities
Product Launches
Merger, Acquisition, Collaborations
Regulatory Guideline and Compliances
Key Developments
PEST Analysis
Technology Landscape
Service Cost Analysis

4. Global Prefilled Syringes Market, By Material, 2025-2032, (US$ Billion)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Glass
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)
Plastic/Polymer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)

5. Global Prefilled Syringes Market, By Drug Type, 2025-2032, (US$ Billion)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Biologics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)
  - Monoclonal Antibodies
  - Blood Products
  - Others (Erythropoietin, Therapeutic proteins, among others)
Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)
  - Conjugated Vaccines
  - Live Attenuated Vaccines
  - Recombinant Vaccines
  - Others (Virus-like particles (VLPs), Viral vector vaccines)
Insulin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)
Anticoagulants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)
Flush Saline Syringes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)

6. Global Prefilled Syringes Market, By Design, 2025 - 2032, (US$ Billion)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Single-chamber
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)
Dual-chamber
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)
Multi-chambered
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)

7. Global Prefilled Syringes Market, By Product Type, 2025 - 2032, (US$ Billion)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Staked in-needle pre-filled syringes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)
Needle-free pre-filled syringes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)

8. Global Prefilled Syringes Market, By Usability, 2025 - 2032, (US$ Billion)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Disposable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)
Reusable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)

9. Global Prefilled Syringes Market, By Manufacturing Method, 2025 - 2032, (US$ Billion)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Captive
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)
Merchant
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)

10. Global Prefilled Syringes Market, By End User, 2025 - 2032, (US$ Billion

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segments Trends
Hospital
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)
Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)
Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)

11. Global Prefilled Syringes Market, By Region, 2025 - 2032, (US$ Billion)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Regions, 2021-2032
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Material, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Design, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Usability, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Method, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2025 - 2032, (US$ Billion)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Material, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Design, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Usability, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Method, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2025 - 2032, (US$ Billion)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Material, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Design, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Usability, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Method, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2025 - 2032, (US$ Billion)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Material, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Design, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Usability, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Method, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2025 - 2032, (US$ Billion)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Material, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Design, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Usability, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Method, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2025 - 2032, (US$ Billion)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Material, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Design, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Usability, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Method, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2025 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2025 - 2032, (US$ Billion)
  - North Africa
  - Central Africa
  - South Africa

12. Competitive Landscape

Gerresheimer AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Becton, Dickinson and Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
West Pharmaceutical Services, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Terumo Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Nipro Europe Group Companies
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
B.Braun SE
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
GSK plc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Bayer AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Polymedicure
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Amsino International, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Leeford Healthcare Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Torrent Pharmaceuticals Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Regeneron Pharmaceuticals Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Ypsomed AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
SOL-Millennium
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Stevanato Group S.p.A.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies